OpenVSafe by OpenVAERS
Search V-safe

4KJ-20923-15366

2 vaccinations 8 coded responses 23 check-ins 8 free-text entries 0 call cases
Sex
Male
Age at first dose
36-40
ZIP prefix
974 / OR
Registered
2021-01-26
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-26
    Registered in v-safe
  2. 2021-01-26
    Dose 1 — Moderna
  3. 2021-01-26
    Survey response — day 0, dose 1
    MedDRA: Injection site discomfort — Feeling: Good · Site: Pain
    Free text: injection site discomfort consistent with prior vaccine experiences
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-01-28
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  5. 2021-01-29
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-01-31
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-02-01
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-02-02
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-02-09
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  10. 2021-02-18
    Survey response — day 21, dose 1
    MedDRA: Eczema, Pre-existing disease — Feeling: Good
    Free text: Eczema flare-up.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-02-23
    Health check-in — day 28, dose 1
    Feeling: Fair
    Adult check-in
  12. 2021-03-02
    Dose 2 — Moderna
  13. 2021-03-02
    Health check-in — day 0, dose 2
    Feeling: Fair · Chills, Fatigue or tiredness, Nausea
    Adult check-in
  14. 2021-03-03
    Survey response — days 1–6 daily, dose 2
    MedDRA: Chills, Fatigue, Hyperhidrosis, Nausea, Pain, Sleep disorder — Feeling: Fair · Site: Pain, Redness · Fever · Chills, Muscle or body aches, Fatigue or tiredness, Nausea
    Free text: body ache, fatigue, chills, nausea onset ~8 hours post-vaccine. Chills, aches, sweating, sleep disruption overnight, symptoms began to subside today, ~28 hours post-vaccine. Still experiencing mild but persistent fatigue
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-03-04
    Survey response — days 1–6 daily, dose 2
    MedDRA: Chills, Night sweats, Sleep disorder — Feeling: Fair · Fatigue or tiredness
    Free text: sweating and chills overnight again, less severe and less disruptive of sleep than the first night
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-03-05
    Survey response — days 1–6 daily, dose 2
    MedDRA: Chills, Fatigue, Night sweats, Pain — Feeling: Good · Site: Itching · Joint pains, Fatigue or tiredness
    Free text: still some chills and sweating overnight but less than previous 2 nights... overnight symptoms and fatigue/ache seem to be gradually tapering down at similar rate to the sensation of fatigue after the first dose.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-03-06
    Survey response — days 1–6 daily, dose 2
    MedDRA: Muscle tightness — Feeling: Fair · Site: Itching · Fatigue or tiredness, Nausea
    Free text: body wide muscular tension
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-03-08
    Survey response — days 1–6 daily, dose 2
    MedDRA: Fatigue, Muscle discomfort, Musculoskeletal discomfort — Feeling: Good · Muscle or body aches, Fatigue or tiredness
    Free text: mild muscle/joint discomfort and noticeable fatigability consistent with the ~week after first dose.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-03-10
    Health check-in — day 7, dose 2
    Feeling: Good · Muscle or body aches, Fatigue or tiredness, Nausea
    Adult check-in
  20. 2021-03-16
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-03-23
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-03-30
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-04-06
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-04-13
    Survey response — day 42, dose 2
    MedDRA: Pre-existing disease, Psoriasis — Feeling: Good
    Free text: Beginning ~10 days post vaccine and continuing ~2 weeks I had a flare up of psoriasis symptoms.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  25. 2021-06-01
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-09-02
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-01-26Moderna
22021-03-02Moderna

Free text

Release 2 — day 0, dose 1

2021-01-26

Systemic reaction (other): injection site discomfort consistent with prior vaccine experiences

Release 4 — day 21, dose 1

2021-02-18

Symptoms: Eczema flare-up.

Release 5 — days 1–6 daily, dose 2

2021-03-03

Systemic reaction (other): body ache, fatigue, chills, nausea onset ~8 hours post-vaccine. Chills, aches, sweating, sleep disruption overnight, symptoms began to subside today, ~28 hours post-vaccine. Still experiencing mild but persistent fatigue

2021-03-04

Systemic reaction (other): sweating and chills overnight again, less severe and less disruptive of sleep than the first night

2021-03-05

Systemic reaction (other): still some chills and sweating overnight but less than previous 2 nights... overnight symptoms and fatigue/ache seem to be gradually tapering down at similar rate to the sensation of fatigue after the first dose.

2021-03-06

Systemic reaction (other): body wide muscular tension

2021-03-08

Systemic reaction (other): mild muscle/joint discomfort and noticeable fatigability consistent with the ~week after first dose.

Release 7 — day 42, dose 2

2021-04-13

Symptoms: Beginning ~10 days post vaccine and continuing ~2 weeks I had a flare up of psoriasis symptoms.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDEczema ✓ ✓ ✓
SDPre-existing disease ✓ ✓ ✓
SDPsoriasis ✓ ✓ ✓
SROChills ✓ ✓ ✓
SROFatigue ✓ ✓ ✓
SROHyperhidrosis ✓ ✓ ✓
SROInjection site discomfort ✓ ✓ ✓
SROMuscle discomfort ✓ ✓ ✓
SROMuscle tightness ✓ ✓ ✓
SROMusculoskeletal discomfort ✓ ✓ ✓
SRONausea ✓ ✓ ✓
SRONight sweats ✓ ✓ ✓
SROPain ✓ ✓ ✓
SROSleep disorder ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release